CINECA IRIS Institutional Research Information System

ANTONIOLI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.989
AS - Asia 6.375
EU - Europa 5.973
SA - Sud America 1.035
AF - Africa 346
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 5
Totale 27.747
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.612
IT - Italia 2.438
SG - Singapore 2.067
CN - Cina 1.796
HK - Hong Kong 1.184
BR - Brasile 886
SE - Svezia 824
DE - Germania 536
BG - Bulgaria 451
VN - Vietnam 394
GB - Regno Unito 344
FI - Finlandia 278
CA - Canada 263
RU - Federazione Russa 263
TR - Turchia 254
AT - Austria 253
IN - India 152
CI - Costa d'Avorio 148
FR - Francia 116
UA - Ucraina 116
KR - Corea 104
NL - Olanda 88
JP - Giappone 81
MX - Messico 65
PL - Polonia 64
AR - Argentina 62
BE - Belgio 45
SN - Senegal 45
BD - Bangladesh 44
PK - Pakistan 44
CH - Svizzera 39
IQ - Iraq 35
NG - Nigeria 34
UZ - Uzbekistan 31
ZA - Sudafrica 30
ID - Indonesia 29
IR - Iran 26
ES - Italia 25
VE - Venezuela 24
MA - Marocco 20
EG - Egitto 19
AU - Australia 18
EC - Ecuador 18
CZ - Repubblica Ceca 16
SA - Arabia Saudita 16
LT - Lituania 14
AE - Emirati Arabi Uniti 13
CO - Colombia 13
PY - Paraguay 13
AZ - Azerbaigian 11
KE - Kenya 11
MY - Malesia 11
PH - Filippine 11
PT - Portogallo 11
TW - Taiwan 11
IE - Irlanda 10
CL - Cile 9
DZ - Algeria 9
JM - Giamaica 9
PA - Panama 8
BJ - Benin 7
HN - Honduras 7
IL - Israele 7
KZ - Kazakistan 7
LB - Libano 7
TN - Tunisia 7
AL - Albania 6
HU - Ungheria 6
KG - Kirghizistan 6
NO - Norvegia 6
OM - Oman 6
DO - Repubblica Dominicana 5
NZ - Nuova Zelanda 5
PE - Perù 5
BY - Bielorussia 4
DK - Danimarca 4
GH - Ghana 4
JO - Giordania 4
QA - Qatar 4
RO - Romania 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AO - Angola 3
CG - Congo 3
EU - Europa 3
GD - Grenada 3
NP - Nepal 3
PS - Palestinian Territory 3
UY - Uruguay 3
BS - Bahamas 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
LV - Lettonia 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
SV - El Salvador 2
TH - Thailandia 2
Totale 27.723
Salva come PNG Salva come JPEG
Città #
Ashburn 1.504
Fairfield 1.262
Woodbridge 1.175
Hong Kong 1.155
Singapore 1.066
Dallas 994
Ann Arbor 940
Houston 848
Chandler 782
Santa Clara 773
Seattle 497
Wilmington 480
Cambridge 448
Sofia 446
Shanghai 439
Milan 402
Beijing 385
Serra 376
New York 328
Boardman 264
Los Angeles 234
Princeton 192
Ottawa 189
Vienna 174
Lawrence 168
Pisa 168
Medford 150
Abidjan 148
Florence 142
Izmir 131
Munich 120
Jacksonville 119
Hefei 118
Dong Ket 116
Des Moines 109
London 102
Rome 95
Nanjing 93
Istanbul 89
Chicago 85
Seoul 84
Bremen 81
Buffalo 79
Helsinki 76
São Paulo 75
Redondo Beach 74
Dearborn 73
Frankfurt am Main 70
Ho Chi Minh City 62
San Jose 61
Tokyo 57
Turku 57
Lucca 55
Lappeenranta 50
Nanchang 49
Council Bluffs 47
Dakar 45
Lancaster 44
Ogden 44
Hanoi 43
Brussels 42
Warsaw 41
Redwood City 40
San Diego 40
Falls Church 39
Columbus 36
Lagos 33
The Dalles 31
Washington 31
Boulder 29
Nuremberg 29
Bern 28
Tashkent 28
Montignoso 27
Pune 27
Phoenix 26
Bologna 25
Guangzhou 25
Rio de Janeiro 25
Toronto 25
Livorno 24
Tianjin 24
Atlanta 23
Changsha 23
Naples 23
Fuzhou 22
Hebei 22
Kunming 22
Montreal 22
Marseille 21
Chennai 20
Porto Alegre 20
Jüchen 19
Norwalk 19
Brooklyn 18
Belo Horizonte 17
Paris 17
Brasília 16
Jiaxing 16
Kent 16
Totale 19.563
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 504
Preparation of isoindoline derivatives for use as AMPK activators 317
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 286
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 258
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 247
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 245
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 239
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 234
Derivati benzofuranici come attivatori di AMPK 226
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 219
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 217
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 209
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 206
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 197
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 197
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 194
CD39 and CD73 in immunity and inflammation 194
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 192
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 192
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 190
Role of Cyclooxygenase isoforms in the neuromodulation of colonic motility in Humans and Mice 189
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 187
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 185
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 183
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 182
Cyclooxygenase expression in neuromuscular compartment of normal and inflamed colon 181
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 181
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations 181
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 180
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 180
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 180
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 179
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 178
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 178
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 177
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 176
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 176
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 174
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 173
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 172
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 171
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 171
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 170
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 170
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 169
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 168
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 168
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 168
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 168
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 166
Allopurinol adherence among patients with gout: an Italian general practice database study 166
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 165
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 165
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 164
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 164
Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases 164
Role of A2a adenosine in the regulation of colonic motility in normal human colon 163
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 163
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 161
Preparation of benzofuran derivatives for use as AMPK activators 160
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 160
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 160
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 159
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 158
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 158
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 158
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 157
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 156
Donepezil improves vascular function in a mouse model of Alzheimer's disease 156
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 155
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 155
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 155
Transient acute liver failure complicating transurethral resection syndrome 154
Adenosine and inflammation: what's new on the horizon? 153
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 153
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 152
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 152
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 152
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 150
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 150
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 150
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 149
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 148
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 148
Anti-CD73 in cancer immunotherapy: awakening new opportunities 148
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 146
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 146
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 146
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 145
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 144
Risankizumab for the treatment of moderate to severe psoriasis 144
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms 144
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 144
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 143
Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting 143
Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing 143
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 143
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 142
Adenosine regulation of the immune system 140
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis 139
Totale 17.677
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.041 0 0 0 0 0 0 66 127 229 201 106 312
2021/20222.056 37 87 66 105 390 307 74 115 127 86 138 524
2022/20232.925 334 398 220 282 285 387 37 229 479 49 190 35
2023/20242.469 221 223 285 193 360 427 63 115 106 96 132 248
2024/20256.733 82 252 109 397 552 730 649 299 735 864 710 1.354
2025/20264.834 532 896 1.093 724 855 669 65 0 0 0 0 0
Totale 28.522